Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 6/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21514041 | 0.84 | ALDH1A1 (0.36) | IDO1FFAR1 | |
| SCHEMBL5179689 | 0.78 | HDAC8 (0.43) | HDAC8CA12CA1CA2CA4 | |
| SCHEMBL3840593 | 0.78 | HDAC8 (0.43) | HDAC8CA12CA1CA2CA4 | |
| SCHEMBL127369 | 0.76 | IDO1 (0.69) | IDO1LOXL2 | |
| SCHEMBL28871 | 0.76 | HDAC8 (0.59) | HDAC8CA12CA1CA2CA4 | |
| SCHEMBL23091413 | 0.74 | IDO1 (0.46) | IDO1FFAR1CYP2A6LOXL2 | |
| SCHEMBL935811 | 0.74 | CYP2A6 (0.58) | HDAC8CA12CA1CA2CA4 | |
| SCHEMBL1253137 | 0.74 | TRPA1 (0.43) | HDAC8CA12CA1CA2CA4 | |
| SCHEMBL720296 | 0.74 | HDAC8 (0.40) | HDAC8CA12CA1CA2CA4 | |
| SCHEMBL19437245 | 0.74 | HDAC8 (0.40) | HDAC8CA12CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0759457-B2 | Weather and soiling-resistant silicone-containing coating composition | SHINETSU CHEMICAL CO (JP) | 2004-06-16 | — | — | EP | claimed |
| EP-0759457-B1 | Weather and soiling-resistant silicone-containing coating composition | SHINETSU CHEMICAL CO (JP) | 2001-06-13 | — | — | EP | claimed |
| US-12613191-B2 | Multiplexed Raman molecular imaging | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2026-04-28 | — | — | US | disclosed |
| US-20240085335-A1 | MULTIPLEXED RAMAN MOLECULAR IMAGING | UNIVERSITY OF SOUTHERN CALIFORNIA | 2024-03-14 | — | — | US | disclosed |
| WO-2022157674-A1 | MULTIPLEXED RAMAN MOLECULAR IMAGING | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2022-07-28 | — | — | WO | disclosed |
| US-20050101063-A1 | Three-terminal field-controlled molecular devices | TOUR JAMES M (US) | 2005-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12613191-B2 | Multiplexed Raman molecular imaging | FABP1, SCNN1G, VIL1 | IDO1 2635/4885HDAC8 4601/4885CA12 151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.